Quest Diagnostics IncorporatedDGXNYSE
Loading
Net Income Growth Under PressureDecelerating
Percentile Rank51
Year-over-Year Change
Year-over-year net income growth rate
Latest
0.00%
↓ 100% vs avg
Percentile
P51
Within normal range
Streak
1 qtr
Consecutive growthDecelerating
Average
8.89%
Historical baseline
| Period | Value |
|---|---|
| Q4 2025 | 0.00% |
| Q3 2025 | -13.12% |
| Q2 2025 | 28.18% |
| Q1 2025 | -0.90% |
| Q4 2024 | -1.77% |
| Q3 2024 | -1.31% |
| Q2 2024 | 18.04% |
| Q1 2024 | 1.04% |
| Q4 2023 | -14.67% |
| Q3 2023 | -4.26% |
| Q2 2023 | 16.34% |
| Q1 2023 | 100.00% |
| Q4 2022 | -60.24% |
| Q3 2022 | 9.01% |
| Q2 2022 | -34.18% |
| Q1 2022 | -9.00% |
| Q4 2021 | -22.66% |
| Q3 2021 | -19.90% |
| Q2 2021 | 34.19% |
| Q1 2021 | -18.75% |
| Q4 2020 | 1.77% |
| Q3 2020 | 207.61% |
| Q2 2020 | 85.86% |
| Q1 2020 | -60.87% |
| Q4 2019 | 18.22% |
| Q3 2019 | 3.88% |
| Q2 2019 | 26.38% |
| Q1 2019 | 29.37% |
| Q4 2018 | -40.57% |
| Q3 2018 | -3.20% |
| Q2 2018 | 24.43% |
| Q1 2018 | -30.43% |
| Q4 2017 | 58.13% |
| Q3 2017 | -17.10% |
| Q2 2017 | 18.40% |
| Q1 2017 | 5.16% |
| Q4 2016 | -18.42% |
| Q3 2016 | -2.06% |
| Q2 2016 | 88.35% |
| Q1 2016 | -45.21% |